Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wittekindt

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
HNO|August 10, 2002
[Quality assurance indicators in an ENT practice]C Wittekindt, G Kassens, S Bramlage, et al.
HNO|July 22, 2005
[An accessory retropharyngeal bone as a rare cause of dysphagia]D Beutner, S F Preuss, A I Schulz, et al.
International Journal of Pediatric Otorhinolaryngology|February 13, 2001
Progressive hearing loss in hearing impaired children: immediate results of antiphlogistic--rheologic infusion therapyM Streppel, C Wittekindt, H von Wedel, et al.
HNO|July 15, 2015
[Spontaneous bone regeneration following ceratocystic odontogenic tumor]T Kroll, P Streckbein, C Kähling, et al.
Laryngo- Rhino- Otologie|February 1, 2013
[Current practice of tumour endoscopy in German ENT-clinics]S J Sharma, J J Linke, T Kroll, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 13, 2006
Long-term results of the combined modality therapy for advanced cervical metastatic head and neck squamous cell carcinomaS F Preuss, J P Klussmann, C Wittekindt, et al.
British Journal of Pharmacology|February 28, 2007
New potent and selective cytochrome P450 2B6 (CYP2B6) inhibitors based on three-dimensional quantitative structure-activity relationship (3D-QSAR) analysisL E Korhonen, M Turpeinen, M Rahnasto, et al.
HNO|October 24, 2018
[Update on HPV-associated head and neck cancer-highlights of the 2018 ASCO Annual Meeting]S Tribius, N Würdemann, S Laban, et al.
The Pharmacogenomics Journal|October 10, 2007
Identification of inhibitors of the nicotine metabolising CYP2A6 enzyme--an in silico approachM Rahnasto, C Wittekindt, R O Juvonen, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|March 27, 2018
Patient's perspective on long-term complications after superficial parotidectomy for benign lesions: Prospective analysis of a 2-year follow-upP Wolber, G F Volk, L Horstmann, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
HNO|August 10, 2002
[Quality assurance indicators in an ENT practice]C Wittekindt, G Kassens, S Bramlage, et al.
HNO|July 22, 2005
[An accessory retropharyngeal bone as a rare cause of dysphagia]D Beutner, S F Preuss, A I Schulz, et al.
International Journal of Pediatric Otorhinolaryngology|February 13, 2001
Progressive hearing loss in hearing impaired children: immediate results of antiphlogistic--rheologic infusion therapyM Streppel, C Wittekindt, H von Wedel, et al.
HNO|July 15, 2015
[Spontaneous bone regeneration following ceratocystic odontogenic tumor]T Kroll, P Streckbein, C Kähling, et al.
Laryngo- Rhino- Otologie|February 1, 2013
[Current practice of tumour endoscopy in German ENT-clinics]S J Sharma, J J Linke, T Kroll, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 13, 2006
Long-term results of the combined modality therapy for advanced cervical metastatic head and neck squamous cell carcinomaS F Preuss, J P Klussmann, C Wittekindt, et al.
British Journal of Pharmacology|February 28, 2007
New potent and selective cytochrome P450 2B6 (CYP2B6) inhibitors based on three-dimensional quantitative structure-activity relationship (3D-QSAR) analysisL E Korhonen, M Turpeinen, M Rahnasto, et al.
HNO|October 24, 2018
[Update on HPV-associated head and neck cancer-highlights of the 2018 ASCO Annual Meeting]S Tribius, N Würdemann, S Laban, et al.
The Pharmacogenomics Journal|October 10, 2007
Identification of inhibitors of the nicotine metabolising CYP2A6 enzyme--an in silico approachM Rahnasto, C Wittekindt, R O Juvonen, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|March 27, 2018
Patient's perspective on long-term complications after superficial parotidectomy for benign lesions: Prospective analysis of a 2-year follow-upP Wolber, G F Volk, L Horstmann, et al.
Pageof 5